Tatva Chintan Pharma IPO
Tatva Chintan Pharma Chem Limited is one of the largest manufacturers of SDAs for zeolites in the country. The company specialises in phase transfer catalysts, structure-directing agents and agrochemical intermediates, and several other speciality chemicals.
In FY2020, Tatva Chintan Pharma generated 76% of its revenue from exports. The company exports its products to more than 25 countries globally. It has a robust customer base in industries like automotive, petroleum, agrochemicals, pharmaceutical dyes and pigments, personal care, and paints and coatings.
IPO objectives
- Obtain funds for expanding Dahej manufacturing facility.
- To fund the upgradation of the company’s R&D facilities in Vadodara.
- For addressing general corporate purposes.
Tatva Chintan Pharma IPO - Details
The offer size of Tatva Chintan Pharma IPO is Rs. 500 crores. The company will issue new equity shares amounting to Rs. 225 crores and offer for sale by unitholders and promoters totalling Rs. 275 crores.
Opening Date
July 16, 2021
Closing Date
July 20, 2021
Price Band
₹1073 to ₹1083
per equity share
Issue Size
₹ 500 Cr
Face Value
₹10
per equity share
Market Lot
13 Shares
Opening Date
July 16, 2021
Closing Date
July 20, 2021
Price Band
₹1073 to ₹1083
per equity share
Issue Size
₹ 500 Cr
Face Value
₹10
per equity share
Market Lot
13 Shares
Listing at NSE, BSE
Tatva Chintan Pharma IPO Important Dates
IPO Open Date | 16-Jul-21 |
---|---|
IPO Close Date | 20-Jul-21 |
Basis Of Allotment Date | 22-Jul-21 |
Initiation Of Refunds | 26-Jul-21 |
Credit Of Shares To Demat ACcount |
28-Jul-21 |
IPO Listing Date | 29-Jul-21 (tentative) |
Initiation of Refund | 27-Jul-21 |
Tatva Chintan Pharma IPO Latest News and Subscription Status Today [Live]
At 05:00 p.m.
- This IPO has been subscribed 180.35x by 5:00 PM. on Day 3
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 185.23x
- (NII) Non-institutional buyers: 512.22x
- (RII) Retail Individual buyers: 35.34x
At 04:00 p.m.
- This IPO has been subscribed 179.62x by 4:00 PM. on Day 3
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 185.23x
- (NII) Non-institutional buyers: 509.93x
- (RII) Retail Individual buyers: 4.384x
At 02:45 p.m.
- This IPO has been subscribed 134.31x by 2:45 PM. on Day 3
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 107.58x
- (NII) Non-institutional buyers: 406.65x
- (RII) Retail Individual buyers: 32.86x
At 01:45 p.m.
- This IPO has been subscribed 53.19x by 1:45 PM. on Day 3
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 18.85x
- (NII) Non-institutional buyers: 187.44x
- (RII) Retail Individual buyers: 15.26x
At 12:45 p.m.
- This IPO has been subscribed 31.07x by 12:45 PM. on Day 3
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 2.60x
- (NII) Non-institutional buyers: 108.80x
- (RII) Retail Individual buyers: 14.03x
At 11:35 a.m.
- This IPO has been subscribed 9.37x by 11:35 AM. on Day 3
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 2.55x
- (NII) Non-institutional buyers: 9.63x
- (RII) Retail Individual buyers: 13.16x
At 10:30 a.m.
- This IPO has been subscribed 8.11x by 10:30 AM. on Day 3
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.71x
- (NII) Non-institutional buyers: 8.27x
- (RII) Retail Individual buyers: 12.28x
At 05:00 p.m.
- This IPO has been subscribed 6.86x by 5:05 PM. on Day 2
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.71x
- (NII) Non-institutional buyers: 4.94x
- (RII) Retail Individual buyers: 11.21x
At 04:35 p.m.
- This IPO has been subscribed 6.65x by 4:35 PM. on Day 2
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.71x
- (NII) Non-institutional buyers: 4.35x
- (RII) Retail Individual buyers: 11.03x
At 04:05 p.m.
- This IPO has been subscribed 6.32x by 4:05 PM. on Day 2
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.50x
- (NII) Non-institutional buyers: 4.13x
- (RII) Retail Individual buyers: 10.59x
At 02:35 p.m.
- This IPO has been subscribed 5.48x by 2:35 PM. on Day 2
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.50x
- (NII) Non-institutional buyers: 2.40x
- (RII) Retail Individual buyers: 9.65x
At 12:50 p.m.
- This IPO has been subscribed 4.83x by 12:50 PM. on Day 2
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.50x
- (NII) Non-institutional buyers: 1.84x
- (RII) Retail Individual buyers: 8.59x
At 11:50 a.m.
- This IPO has been subscribed 4.25x by 11:50 AM. on Day 2
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.50x
- (NII) Non-institutional buyers: 1.40x
- (RII) Retail Individual buyers: 7.62x
At 10:40 a.m.
- This IPO has been subscribed 3.13x by 10:40 AM. on Day 2
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.50x
- (NII) Non-institutional buyers: 0.63x
- (RII) Retail Individual buyers: 5.71x
At 05:00 p.m.
- This IPO has been subscribed 2.46x by 5.00 PM. on Day 1
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.50x
- (NII) Non-institutional buyers: 0.38x
- (RII) Retail Individual buyers: 4.47x
At 04:05 p.m.
- This IPO has been subscribed 3.73x by 4.05 PM. on Day 1
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.50x
- (NII) Non-institutional buyers: 0.73x
- (RII) Retail Individual buyers: 6.85x
At 03:05 p.m.
- This IPO has been subscribed 3.15x by 3.05 PM. on Day 1
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.01x
- (NII) Non-institutional buyers: 0.61x
- (RII) Retail Individual buyers: 6.04x
At 01:58 p.m.
- This IPO has been subscribed 2.68x by 1:58 PM. on Day 1
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.01x
- (NII) Non-institutional buyers: 0.43x
- (RII) Retail Individual buyers: 5.18x
At 12:53 p.m.
- This IPO has been subscribed 2.16x by 12:53 PM. on Day 1
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.01x
- (NII) Non-institutional buyers: 0.33x
- (RII) Retail Individual buyers: 4.18x
At 11:58 a.m.
- This IPO has been subscribed 1.48x by 11:58 AM. on Day 1
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.00
- (NII) Non-institutional buyers: 0.12x
- (RII) Retail Individual buyers: 2.91x
At 11:00 a.m.
- This IPO has been subscribed 0.93x by 11:00 AM. on Day 1
- It is a public issue of 32,61,882 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: xxx
- (NII) Non-institutional buyers: 0.04x
- (RII) Retail Individual buyers: 1.84x
Why should you invest in Tatva Chintan Pharma IPO?
Tatva Chintan Pharma Chem is a niche player in the space of speciality chemicals. Moreover, when compared to its market peers, the company’s IPO issue price is reasonable.
Financial highlights
In FY2022, so far, the company’s exports stand at Rs. 211.99 crores, accounting for 70.58% of its revenue from operations.
Financial year | Total Revenue | Total Assets | Profit after tax |
---|---|---|---|
March 31 2019 | Rs. 2,068.01 million | Rs. 1,875.08 million | Rs. 205.43 million |
March 31 2020 | Rs. 2,646.22 million | Rs. 2,489.38 million | Rs. 377.89 million |
March 31 2021 | Rs. 3,062.92 million | 3,148.03 million | Rs. 522.62 million |
How to apply for Tatva Chintan Pharma IPO?
You can apply for the Tatva Chintan Pharma IPO in these ways:
UPI
Link your bank account to a reliable UPI ID and register it with your Angel One account. Proceed to book Tatva Chintan Pharma IPO shares using the ID, confirm the payment on the UPI app, and block the amount for allotment.
Demat Account
1. If you are already a client of Angel One, apply directly for Tatva Chintan Pharma IPO, click here.
2. If you’re a new investor Open DEMAT Account for free with Angel One to begin your investment journey.
Tatva Chintan Pharma IPO - Noteworthy Highlights
These are a few noteworthy highlights of Tatva Chintan Pharma –
- It is India’s leading manufacturer of phase transfer catalyst and structure-directing agents.
- The company has a strong foothold in over 25 countries.
- It boasts a strong customer base across several crucial industries.
- Its clientele includes SRF, Laurus Laboratories, Asian Paints, Merck and Divis Laboratories, and Bayer.
- Its key products, namely methyl triocyl ammonium chloride and methyl tributyl ammonium chloride are likely to register more than 3% CAGR worldwide.
Tatva Chintan Pharma IPO - SWOT Analysis
Tatva Chintan Pharma IPO FAQs
Who is the registrar for Tatva Chintan Pharma IPO?
What is the minimum order quantity for Tatva Chintan Pharma IPO?
Who are the lead managers of the Tatva Chintan IPO?
How many manufacturing units of Tatva Chintan Pharma are there?
Be a Part of IPO Success Stories!
Join our 2.5 Cr+ happy customers